Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M205424200 on October 24, 2002

J. Biol. Chem., Vol. 278, Issue 1, 27-36, January 3, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/1/27    most recent
M205424200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Wang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Wang, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PAX3-FKHR Transformation Increases 26 S Proteasome-dependent Degradation of p27Kip1, a Potential Role for Elevated Skp2 Expression*

Lei Zhang and Chiayeng WangDagger

From the Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago, Chicago, Illinois 60612

PAX3-FKHR is an oncogenic form of the developmental regulator Pax3 transcription factor. PAX3-FKHR results from a t(2,13) chromosomal translocation, a unique genetic marker of alveolar rhabdomyosarcoma. In this study, we showed that ectopic expression of PAX3-FKHR, but not Pax3, in fibroblasts altered cell cycle control and accelerated G0/G1 to S cell cycle transition. PAX3-FKHR-expressing cells had reduced expression of p27Kip1 protein, a key cell cycle regulator. The reduction in p27Kip1 levels by PAX3-FKHR resulted from destabilization of p27Kip1 as shown by cycloheximide treatment and in vivo pulse-chase labeling experiments. The reduced p27Kip1 protein level in PAX3-FKHR-expressing cells was restored to the level of control cells by treatment with chemical inhibitors that specifically blocked 26 S proteasome activity. Along with the reduction in p27Kip1 protein, PAX3-FKHR-expressing cells exhibited elevated expression of F-box Skp2 protein, a substrate-specific component of SCF (Skp1-Cullin-F box protein) ligase involved in the cell cycle-dependent control of p27Kip1 ubiquitination and 26 S proteasome dependent degradation. Finally, we showed that ectopic expression of p27Kip1 in PAX3-FKHR-expressing cells significantly reduced the proliferation and colony-forming potential of these cells, implicating that down-regulation of p27Kip1 protein played an active role in the PAX3-FKHR-directed cell transformation.


* This work was supported by National Institutes of Health Grant CA-74907 (to C. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: CMBOD, University of Illinois at Chicago, 801South Paulina St., Chicago, IL 60612. Tel.: 312-996-4530; Fax: 312-413-1604; E-mail: chiayeng@tigger.cc.uic.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Nishijo, Q.-R. Chen, L. Zhang, A. T. McCleish, A. Rodriguez, M. J. Cho, S. I. Prajapati, J. A.L. Gelfond, G. B. Chisholm, J. E. Michalek, et al.
Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
Cancer Res., April 1, 2009; 69(7): 2902 - 2911.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sakai, H. Sakaue, T. Nakamura, M. Okada, Y. Matsuki, E. Watanabe, R. Hiramatsu, K. Nakayama, K. I. Nakayama, and M. Kasuga
Skp2 Controls Adipocyte Proliferation during the Development of Obesity
J. Biol. Chem., January 19, 2007; 282(3): 2038 - 2046.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Davicioni, F. Graf Finckenstein, V. Shahbazian, J. D. Buckley, T. J. Triche, and M. J. Anderson
Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas.
Cancer Res., July 15, 2006; 66(14): 6936 - 6946.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Huang, K. M. Regan, F. Wang, D. Wang, D. I Smith, J. M. A. van Deursen, and D. J. Tindall
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation
PNAS, February 1, 2005; 102(5): 1649 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-W. Zhang, M. Kaneda, and I. Morita
The Gap Junction-independent Tumor-suppressing Effect of Connexin 43
J. Biol. Chem., November 7, 2003; 278(45): 44852 - 44856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement